-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Roivant Sciences Ltd. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2020 to Q3 2024.
- Roivant Sciences Ltd. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $12.5M, a 285% increase year-over-year.
- Roivant Sciences Ltd. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $42.3M, a 955% increase year-over-year.
- Roivant Sciences Ltd. annual Income Tax Expense (Benefit) for 2023 was $22.2M, a 328% increase from 2022.
- Roivant Sciences Ltd. annual Income Tax Expense (Benefit) for 2022 was $5.19M, a 1307% increase from 2021.
- Roivant Sciences Ltd. annual Income Tax Expense (Benefit) for 2021 was $369K, a 78.1% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)